Status:
COMPLETED
Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Healthy Toddlers
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-36 years
Phase:
PHASE1
Brief Summary
A study to assess the safety of an investigational meningitis vaccine in toddlers and their immune response to it.
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Aged 18- to 36-months
- Healthy male or female subjects
- Exclusion Criteria
- Prior vaccination with a serogroup B meningococcal vaccine
- Prior history of any invasive meningococcal disease
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2008
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00387569
Start Date
October 1 2006
End Date
March 1 2008
Last Update
May 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Perth, Western Australia, Australia, 6840